disease 4,606 words KG: ent-dise-a344db00
Contents

Huntington's Disease

Disease Info
Transcriptional dysregulationmHTT interacts with transcription factors and chromatin remodelers, altering gene expression patterns critical for neuronal survival
Impaired autophagymHTT aggregates interfere with the autophagy-lysosome pathway, reducing clearance of damaged proteins and organelles
Mitochondrial dysfunctionmHTT impairs mitochondrial electron transport chain function and promotes mitochondrial fragmentation
Axonal transport defectsmHTT disrupts microtubule-based transport of vesicles, organelles, and signaling molecules
Synaptic dysfunctionAlters synaptic plasticity and neurotransmitter release
Subthalamic nucleusNeuronal loss contributes to chorea
ThalamusDegeneration contributes to cognitive symptoms
KG Connections1 knowledge graph edges
DatabasesOMIMOrphanetClinicalTrialsPubMed

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

OMIMMeSHWikipedia

Related Hypotheses (68)

Microglial Efferocytosis Enhancement via GPR32 Superagonists
Score: 0.70
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.77
Circadian Clock-Autophagy Synchronization
Score: 0.76
Circadian-Synchronized Proteostasis Enhancement
Score: 0.74
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.74
Senescence-Induced Lipid Peroxidation Spreading
Score: 0.73
Phase-Separated Organelle Targeting
Score: 0.73
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.73
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.73
TFAM overexpression creates mitochondrial donor-recipient gr
Score: 0.73
Magnetosonic-Triggered Transferrin Receptor Clustering
Score: 0.72
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.71
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.71
HDAC3-Selective Inhibition for Clock Reset
Score: 0.71
Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.71
Autophagosome Maturation Checkpoint Control
Score: 0.71
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.71
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.70
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.70
Axonal RNA Transport Reconstitution
Score: 0.70
pg 1/4Next →

Related Analyses (29)

Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived

Related Experiments (12)

Tau ASO Therapy
validation · proposed · Score: 0.40
s:** - Temporal analysis showing mitochondrial defects prece
falsification · proposed · Score: 0.40
Epigenetic Dysregulation in Huntington's Disease — Therapeut
validation · completed · Score: 0.40
Experiment Index
validation · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40

Knowledge Graph (1 edges)

therapeutics-huntingtons-disease-treatment describes ent-dise-a344db00

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.